PERMIAN RESOURCES CORP (PR)
Permian Resources Declares Quarterly Cash Dividend
ARGENX SE (ARGX)
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
FLUOR CORP (FLR)
Fluor to Participate in Upcoming Investor Conferences
VANDA PHARMACEUTICALS INC. (VNDA)
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
MANNKIND CORP (MNKD)
MannKind Reports First Quarter 2026 Financial Results and Provides Business Update
SYNDAX PHARMACEUTICALS INC (SNDX)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Veradigm Inc (MDRX)
Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices
QUANTERIX CORP (QTRX)
Quanterix Releases Financial Results for the First Quarter of 2026
ASCENDIS PHARMA A/S (ASND)
New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio to Participate in May and June Investor Conferences